Benchling, the platform for scientific progress, today announced a strategic collaboration with Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform created by Eli Lilly and ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

The initial promise of AI was focused on cost-cutting and productivity through incremental automation. Tools like robotic ...

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...

What is patient privacy for? The Hippocratic Oath, thought to be one of the earliest and most widely known medical ethics ...

Dec 18 (Reuters) - Moderna (MRNA.O), opens new tab will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental bird flu vaccine, the U.S.

Recent developments in machine learning techniques have been supported by the continuous increase in availability of high-performance computational resources and data. While large volumes of data are ...

Mixed options sentiment in Moderna (MRNA), with shares down $2.19 near $32.71. Options volume relatively light with 46k contracts traded and puts leading calls for a put/call ratio of 1.03, compared ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

Moderna has rallied ~23%, but I maintain a 'Sell' and 'market underperform' rating due to deteriorating fundamentals. MRNA’s recent rally is driven by improved liquidity, cost discipline, and a $1.5 ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.